Stockscreener 앱 받기
80.87
3.15%
2.5942
Nuvalent Inc 주식(NUVL)의 최신 뉴스
Is Nuvalent, Inc. (NUVL) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey
Nuvalent’s (NUVL) “Buy” Rating Reiterated at HC Wainwright - Defense World
Nuvalent stock reiterates buy rating on FDA approval potential - MSN
Nuvalent CEO Porter James Richard sells shares worth $2.05m - MSN
JPMorgan Chase & Co. Has $3.55 Million Stake in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent, Inc. (NASDAQ:NUVL) CEO James Richard Porter Sells 27,000 Shares - MarketBeat
Nuvalent CEO Porter James Richard sells shares worth $2.05m By Investing.com - Investing.com Canada
HC Wainwright Reiterates Buy Rating for Nuvalent (NASDAQ:NUVL) - MarketBeat
Nuvalent stock reiterates buy rating on FDA approval potential By Investing.com - Investing.com Canada
Nuvalent's SWOT analysis: biotech stock shows promise amid clinical progress - Investing.com Canada
(NUVL) Trading Report - Stock Traders Daily
Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Nuvalent Announces Corporate Updates and Anticipated Milestones for 2025 - Defense World
Nuvalent's SWOT analysis: biotech's lung cancer drug stock shows promise amid risks - Investing.com Australia
Nuvalent's SWOT analysis: biotech's lung cancer drug stock shows promise amid risks By Investing.com - Investing.com South Africa
Nuvalent’s (NUVL) Outperform Rating Reaffirmed at Wedbush - Defense World
Nuvalent (NASDAQ:NUVL) Given "Outperform" Rating at Wedbush - MarketBeat
Nuvalent chief legal officer sells shares worth $236,182 By Investing.com - Investing.com Nigeria
Nuvalent Details Strategy to Seek First Potential Approval in 2026 and Outlines Key Anticipated 2025 Milestones - Yahoo Finance
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipate - GuruFocus.com
Nuvalent To Share Updated Data From ARROS-1, ALKOVE-1 Trials In September - RTTNews
Nuvalent: A Logical Acquisition Target (NASDAQ:NUVL) - Seeking Alpha
Nuvalent's chief development officer sells shares worth $320,009 By Investing.com - Investing.com Australia
Nuvalent's chief development officer sells shares worth $320,009 - Investing.com India
Nuvalent chief scientific officer sells shares worth $197,853 - Investing.com India
Nuvalent chief scientific officer sells shares worth $197,853 By Investing.com - Investing.com Canada
Nuvalent CEO James Porter sells shares worth $1.38 million By Investing.com - Investing.com Australia
Nuvalent, Inc. (NASDAQ:NUVL) CFO Sells $319,994.88 in Stock - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Insider Sells $197,845.44 in Stock - MarketBeat
Nuvalent chief legal officer sells shares worth $236,182 - Investing.com India
Nuvalent CFO Alexandra Balcom sells $320,009 in stock By Investing.com - Investing.com Canada
Nuvalent’s chief development officer sells shares worth $320,009 By Investing.com - Investing.com Nigeria
Nuvalent CEO James Porter sells shares worth $1.38 million - Investing.com
Nuvalent, Inc. (NASDAQ:NUVL) Shares Sold by Principal Financial Group Inc. - Defense World
Where are the Opportunities in (NUVL) - Stock Traders Daily
Nuvalent to Present New Preclinical Data on HER2-Selective Inhib - GuruFocus.com
HC Wainwright Comments on Nuvalent FY2024 Earnings - Defense World
Nuvalent (NASDAQ:NUVL) Now Covered by Analysts at HC Wainwright - Defense World
Nuvalent stock gains on H.C. Wainwright Buy rating, new target By Investing.com - Investing.com Canada
Nuvalent’s SWOT analysis: promising pipeline drives biotech stock outlook By Investing.com - Investing.com Nigeria
Nuvalent's SWOT analysis: promising pipeline drives biotech stock outlook - Investing.com
Nuvalent's SWOT analysis: promising pipeline drives biotech stock outlook By Investing.com - Investing.com South Africa
1.07%
8.16%
자본화:
|
볼륨(24시간):